v3.26.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY — (UNAUDITED) - USD ($)
$ in Thousands
Total
Common stock
Preferred stock
Capital surplus
Retained earnings
Accumulated other comprehensive income (loss)
Beginning Balance (in shares) at Dec. 31, 2024   21,494,485        
Beginning Balance at Dec. 31, 2024 $ 710,847 $ 215 $ 110,548 $ 434,346 $ 247,698 $ (81,960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (128,950)       (128,950)  
Other comprehensive income (loss) 7,972         7,972
Common dividends declared (13,567)       (13,567)  
Preferred dividends declared (4,456)       (4,456)  
Share-based compensation expense 1,534     1,534    
Issuance of common stock under employee benefit plans (in shares)   20,653        
Issuance of common stock under employee benefit plans 325     325    
Ending Balance (in shares) at Jun. 30, 2025   21,515,138        
Ending Balance at Jun. 30, 2025 573,705 $ 215 110,548 436,205 100,725 (73,988)
Beginning Balance (in shares) at Mar. 31, 2025   21,503,036        
Beginning Balance at Mar. 31, 2025 571,437 $ 215 110,548 435,299 97,714 (72,339)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 12,024       12,024  
Other comprehensive income (loss) (1,649)         (1,649)
Common dividends declared (6,785)       (6,785)  
Preferred dividends declared (2,228)       (2,228)  
Share-based compensation expense 750     750    
Issuance of common stock under employee benefit plans (in shares)   12,102        
Issuance of common stock under employee benefit plans 156     156    
Ending Balance (in shares) at Jun. 30, 2025   21,515,138        
Ending Balance at Jun. 30, 2025 $ 573,705 $ 215 110,548 436,205 100,725 (73,988)
Beginning Balance (in shares) at Dec. 31, 2025 21,169,854 21,169,854        
Beginning Balance at Dec. 31, 2025 $ 565,499 $ 212 110,548 428,247 86,825 (60,333)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 38,351       38,351  
Other comprehensive income (loss) (7,598)         (7,598)
Common dividends declared (13,688)       (13,688)  
Preferred dividends declared (4,456)       (4,456)  
Common stock repurchased (in shares)   (478,715)        
Common stock repurchased (10,668) $ (5)   (10,663)    
Share-based compensation expense 1,520     1,520    
Issuance of common stock under employee benefit plans (in shares)   34,675        
Issuance of common stock under employee benefit plans $ 728     728    
Ending Balance (in shares) at Jun. 30, 2026 20,725,814 20,725,814        
Ending Balance at Jun. 30, 2026 $ 569,688 $ 207 110,548 419,832 107,032 (67,931)
Beginning Balance (in shares) at Mar. 31, 2026   20,813,975        
Beginning Balance at Mar. 31, 2026 558,954 $ 208 110,548 421,609 96,171 (69,582)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 19,888       19,888  
Other comprehensive income (loss) 1,651         1,651
Common dividends declared (6,799)       (6,799)  
Preferred dividends declared (2,228)       (2,228)  
Common stock repurchased (in shares)   (113,208)        
Common stock repurchased (2,744) $ (1)   (2,743)    
Share-based compensation expense 581     581    
Issuance of common stock under employee benefit plans (in shares)   25,047        
Issuance of common stock under employee benefit plans $ 385     385    
Ending Balance (in shares) at Jun. 30, 2026 20,725,814 20,725,814        
Ending Balance at Jun. 30, 2026 $ 569,688 $ 207 $ 110,548 $ 419,832 $ 107,032 $ (67,931)